HONG KONG and SAN FRANCISCO, Jan. 6, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is pleased to announce its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference, taking place on January 13, 2025, in San Francisco, California. The company’s founder, chairwoman, president, and CEO, Dr. Michelle Xia will share the… Continue reading Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference
Tag: Morgan
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 6, 2025 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2025 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the… Continue reading Danaher to Present at J.P. Morgan Healthcare Conference
F&G Annuities & Life Prices Junior Subordinated Notes Offering
DES MOINES, Iowa, Jan. 6, 2025 /PRNewswire/ — F&G Annuities & Life, Inc. (NYSE: FG) (“F&G”) today announced that it priced a public offering of $375 million aggregate principal amount of its 7.300% junior subordinated notes due 2065 (the “notes”). The offering is expected to close on January 13, 2025, subject to satisfaction of customary closing… Continue reading F&G Annuities & Life Prices Junior Subordinated Notes Offering
Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 6, 2025 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take… Continue reading Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 6, 2025 /PRNewswire/ — Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced that the Company will participate at the 43rd Annual J.P. Morgan Healthcare Conference. Warner Biddle, Chief Executive Officer of Kyverna, will present its 2025 strategic priorities and key… Continue reading Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference
Waystar to Present at J.P. Morgan Healthcare Conference
LEHI, Utah and LOUISVILLE, Ky., Jan. 6, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 11:15 a.m. PT. Waystar will provide a live webcast… Continue reading Waystar to Present at J.P. Morgan Healthcare Conference
Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 6, 2025 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 43rd Annual J.P. Morgan Healthcare Conference at 8:15 a.m. Pacific Time on Monday January 13, 2025 in San Francisco. Kyle Gano, Chief Executive Officer, will present at the conference. The live presentation will be webcast and may be accessed… Continue reading Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
LEEDS EQUITY CONTINUES GROWTH OF ITS SENIOR TEAM
NEW YORK, Jan. 6, 2025 /PRNewswire/ — Leeds Equity Partners, LLC (“Leeds Equity”), the New York-based private equity firm, today announced the promotion of Emily Bernstein to Principal. Leeds Equity was founded in 1993 and invests exclusively in the Knowledge Industries. “Having joined our team a year ago with significant prior private equity experience, Emily… Continue reading LEEDS EQUITY CONTINUES GROWTH OF ITS SENIOR TEAM
Smithfield Foods Files Registration Statement for Proposed Initial Public Offering
SMITHFIELD, Va., Jan. 6, 2025 /PRNewswire/ — Smithfield Foods, Inc. (the “Company”), an American food company and an industry leader in value-added packaged meats and fresh pork, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) to sell shares of its common… Continue reading Smithfield Foods Files Registration Statement for Proposed Initial Public Offering
Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that members from its executive leadership team will be attending and participating in investor, industry and business development meetings at the 43rd Annual J.P.… Continue reading Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference